LIPID-ALTERING EFFICACY AND SAFETY PROFILE OF CO-ADMINISTERED EXTENDED RELEASE NIACIN/LAROPIPRANT AND SIMVASTATIN IN PATIENTS WITH DYSLIPIDEMIA

2008 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []